Abstract:ObjectiveTo investigate the changes and potential effects of differentially expressed microRNAs (miRNAs) in the development and progression of liver injury in a mouse model of autoimmune hepatitis (AIH) induced by concanavalin A (ConA). MethodsEight healthy male specific pathogen-free C57BL/6 mice were randomly divided into model group and control group, with four mice in each group. The mice in the model group were given tail vein injection of ConA 15 mg/kg, and those in the control group were given an equal volume of normal saline. All mice were sacrificed after 8 hours of modeling, Total RNA in liver tissue was extracted, gene microarray was used to screen out differentially expressed miRNAs, and target prediction and function analysis were performed for upregulated and downregulated miRNAs. The independent samples t-test was used for comparison of differentially expressed miRNAs between two groups. ResultsThe principal component analysis showed that the inter-group difference of the data extracted by gene microarray met the conditions for further analysis. Compared with the control group, the model group had 31 upregulated miRNAs and 18 downregulated miRNAs in mouse liver, which had a regulatory relationship with 959 target genes (601 upregulated genes and 358 downregulated genes). GO analysis showed that in the model group, the target genes of the upregulated miRNAs mainly had the molecular functions such as “DNA binding” (P=1.47×10-6), participated in the biological processes such as “transcription, DNA-templated” (P=2.36×10-7), and were mainly enriched in the cellular components such as “neuronal cell body” (P=5.99×10-6), while the target genes of the downregulated miRNAs had the molecular functions such as “RNA polymerase II proximal promoter sequence-specific DNA binding” (P=2.49×10-6), participated in the biological processes such as “regulation of transcription, DNA-templated” (P=1.64×10-11), and were mainly enriched in the cellular components such as “nucleoplasm” (P=4.30×10-10). KEGG pathway enrichment analysis showed that the target genes of the upregulated miRNAs were mainly enriched in “Endocytosis” (P=0.000 4), while the target genes of the downregulated miRNAs were mainly enriched in the “Hippo signaling pathway” (P=0.004), and the above functional analysis results were statistically significant (P＜0.05). ConclusionThere are differentially expressed miRNAs in the pathogenesis of AIH, and these differentially expressed miRNAs can provide new targets for the clinical treatment of AIH.

Proteomic Analysis of Differentially Expressed Proteins in Mice with Concanavalin A-induced Hepatitis

Analysis of differential expression of serum proteins in concanavalin A induced liver injury mouse model

A Microarray Analysis of Early Activated Pathways in Concanavalin A-induced Hepatitis

MicroRNA expression profiles related to early stage murine concanavalin A-induced hepatitis.

An experimental study on concanavalin A-induced acute hepatic injury in mice

Identification And Characterization Of Dynamically Regulated Hepatitis-Related Genes In A Concanavalin A-Induced Liver Injury Model

The Differential Effects of Low Dose and High Dose Concanavalin A on Cytokine Profile and Their Importance in Liver Injury

Genes related to the very early stage of ConA-induced fulminant hepatitis: a gene-chip-based study in a mouse model

Protective Effect of Recombinant Hepatical Stimulator Analogue on Concanavalina A-induced Acute Liver Injury in Mice

Protective role of high mobility group box-1 protein antibody in ConA-in-duced liver injury in mice

The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-induced Hepatitis in Mice.

The Fluctuation of Cytokine Mrna Expression Level of a Novel T-cell-mediated Immune Hepatic Fibrosis Model in Balb/c Mice

Comprehensive Immune Cell Analysis of Human Menstrual-Blood-derived Stem Cells Therapy to Concanavalin A Hepatitis

Proteomic analysis of DEN and CCl4-induced hepatocellular carcinoma mouse model

Concanavalin A induced murine model for hepatic fibrosis

Development of the model about concanavalin A-induced experimental liver injury in mice

A functional analysis of differentially expressed microRNAs involved in liver injury in mice with autoimmune hepatitis induced by concanavalin A

Mapping Novel Biomarkers of Liver Injury by Tissue Proteomic Analysis

The mechanism of how anti-IL-18 prevents concanavalin-A-induced hepatic fibrosis on a mouse model.

The protective effects of helix B surface peptide on concanavalin A-induced acute liver injury in mice model

Selection of Reference Genes for Quantitative Real-Time Reverse Transcription-Polymerase Chain Reaction in Concanavalin A-induced Hepatitis Model.